Alaunos Therapeutics Inc. Common Stock (TCRT)
Stock · NASDAQ · Health Care
$2.62as of 10/16/2026
Price chart
Active signals
TCRT Signal Track Record
How signals performed across all stocks →What TCRT's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 36 | -8.6% | 44% | September 18, 2026 |
| Bollinger Band Breakdown | 24 | -10.7% | 33% | September 16, 2026 |
| Bollinger Band BreakoutActive now | 18 | -5.9% | 33% | May 27, 2026 |
| 200-Day Moving Average TouchActive now | 6 | +1.6% | 50% | June 1, 2026 |
| Any 20-session window (baseline) | -9.4% | 33% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About TCRT
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 1
- Website
- alaunos.com/
Fundamentals
- 1-day range
- $2.33$2.99
- Market cap
- $48.60M
- P/E (trailing)
- —
- P/E (forward)
- -3.92
- EPS (trailing)
- $-1.82
- Dividend yield
- —
- Beta
- -0.90
- Avg. volume
- 6.18M
How Alaunos Therapeutics Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 31, 2026 · via SEC EDGAR / Finnhub
Alaunos Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- TCRTAlaunos Therapeutics Inc. Common Stock$2.63▲ 20.64%Market cap $48.60MP/E —$0.719$4.5
- IBOImpact BioMedical Inc. Common Stock$2.68▼ 15.14%Market cap $48.61MP/E 61.61$4.67$10.47
- MCRBSeres Therapeutics Inc. Common Stock$2.46▼ 2.77%Market cap $48.42MP/E —$2.8$29.98
- MREOMereo BioPharma Group plc American Depositary Shares$0.303▼ 1.94%Market cap $47.46MP/E —$0.2$2.37
- FLNAFilana Therapeutics Inc. Common Stock$0.7▼ 7.89%Market cap $46.33MP/E —$0.6701$2.27
- CNTXContext Therapeutics Inc. Common Stock$0.244▲ 1.24%Market cap $46.31MP/E —$0.2358$3.62
- SCYXSCYNEXIS Inc. Common Stock$3.67▼ 6.14%Market cap $51.64MP/E —$3.53$9.12
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| TCRT Alaunos Therapeutics Inc. Common Stock | $48.60M | — | $2.63 | ▲ 20.64% | $0.719$4.5 |
| IBO Impact BioMedical Inc. Common Stock | $48.61M | 61.61 | $2.68 | ▼ 15.14% | $4.67$10.47 |
| MCRB Seres Therapeutics Inc. Common Stock | $48.42M | — | $2.46 | ▼ 2.77% | $2.8$29.98 |
| MREO Mereo BioPharma Group plc American Depositary Shares | $47.46M | — | $0.303 | ▼ 1.94% | $0.2$2.37 |
| FLNA Filana Therapeutics Inc. Common Stock | $46.33M | — | $0.7 | ▼ 7.89% | $0.6701$2.27 |
| CNTX Context Therapeutics Inc. Common Stock | $46.31M | — | $0.244 | ▲ 1.24% | $0.2358$3.62 |
| SCYX SCYNEXIS Inc. Common Stock | $51.64M | — | $3.67 | ▼ 6.14% | $3.53$9.12 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Alaunos Therapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Up 34.32%benzinga · 10/14/2026
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · 9/18/2026
- Unusual volume stocks in Friday's sessionChartMill · 9/18/2026
- Let's take a look at the stocks that are in motion in today's session.ChartMill · 9/18/2026
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga · 9/18/2026
- Alaunos Therapeutics, Inc. Announces Pricing of Registered Direct Offering priced at-the-market under Nasdaq rulesYahoo · 9/18/2026
- Stay updated with the stocks that are on the move in today's pre-market session.ChartMill · 9/18/2026
- Alaunos Therapeutics Announces $1.12M Direct Offering Of 380,469 Shares And Warrants To Purchase Up To 386,654 Shares At $1.46 Per ShareBenzinga · 9/18/2026
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga · 9/18/2026
Insider Activity
Insider Actions →- Holger Weis · August 6, 2026 · Grant4.4K @ $2.01
- Michael Allen Jerman · July 23, 2026 · Grant8.1K @ $1.92
- Holger Weis · July 23, 2026 · Grant4.6K @ $1.92
- Robert W. Postma · July 23, 2026 · Grant8.5K @ $1.92
- Jaime Vieser · July 23, 2026 · Grant8.8K @ $1.92
- Holger Weis · June 30, 2026 · Grant3.9K @ $2.26
- Holger Weis · June 12, 2026 · Grant7.8K @ $2.26
- Holger Weis · May 22, 2026 · Grant3.7K @ $2.37
- Robert W. Postma · April 29, 2026 · Grant6.3K @ $2.59
- Jaime Vieser · April 29, 2026 · Grant6.5K @ $2.59
- Michael Allen Jerman · April 29, 2026 · Grant6.0K @ $2.59
Institutional Ownership
March 31, 2026
- Total shares held
- 109.9K
- Total value held
- $276.8K
- Institutional holders
- 26
- Unknown22.6K
- Unknown21.4K
- Unknown14.1K
- Unknown13.3K
- Unknown10.8K
- Unknown10.5K
- Unknown10.2K
- Unknown2.3K
- Unknown1.8K
- Unknown1.6K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Alaunos Therapeutics (TCRT) Moves in After-Hours Trading
Alaunos Therapeutics was listed among healthcare stocks moving in Friday's after-market session. The stock is currently trading near its support level of $1.97, with an RSI of 30.4 indicating it is in oversold territory. This price action occurs within a 52-week range of $0.97 to $4.59.
Alaunos Therapeutics (TCRT) Moves in After-Hours Trading. Alaunos Therapeutics was listed among healthcare stocks moving in Friday's after-market session. The stock is currently trading near its support level of $1.97, with an RSI of 30.4 indicating it is in oversold territory. This price action occurs within a 52-week range of $0.97 to $4.59.